Home Tags Intensity Therapeutics

Tag: Intensity Therapeutics

FDA fast-tracks Intensity Therapeutics’ breast cancer treatment

“Finding improved therapies for this disease is a critical unmet medical need,” said Lewis H. Bender, president and CEO of Intensity Therapeutics.

Westport biotech Intensity Therapeutics lands $6.5M in funding for cancer treatment

“We look forward to further evaluating the safety and efficacy of INT230-6,” says Intensity Therapeutics Founder and CEO Lewis Bender.

Westport’s Intensity Therapeutics optimistic about potential cancer treatment

The targeted treatment is designed to work on breast, colon, pancreatic, liver, lung and other cancers that do not respond to conventional treatments.